About Cytognos
Cytognos is a Healthcare company based in Santa Marta De Tormes (Spain) founded in 1996, and was acquired by Becton Dickinson in February 2022. Flow cytometry reagents, software, and solutions are developed. Cytognos offers products and services including Infinicyt Software, Antibodies, and Next Generation Flow. Its focus areas include Life Sciences, Oncology, In-Vitro Diagnostic Tests and Diversified. Its legal entity is Cytognos, S.L.
Company details
Development of reagents, software, and solutions for flow cytometry is conducted by Cytognos, which was founded in 1996. Compatibility with most existing flow cytometers is offered by the Infinicyt software, through which multidimensional analysis of antibody panels is enabled. The EuroFlow range of reagents and consumables is directed toward oncology applications, including multiple myeloma, acute lymphoblastic leukemia, B-cell non-Hodgkins lymphoma, and bladder cancer.
- Headquarters Santa Marta De Tormes, Spain
- Stage Acquired
- SectorsHealthcare
- Website cytognos.com
- Social LinkedIn X YouTube
- Acquired by Becton Dickinson (Feb 2022)
- Legal Name Cytognos, S.L.
- InvestorsBD
& 1 more
- Acquired by
Products & Services of Cytognos
Cytognos offers a comprehensive portfolio of products and services, including Infinicyt Software, Antibodies, and Next Generation Flow.
Flow cytometry software for data analysis and visualization
Specialized antibodies for clinical flow cytometry applications
Solutions for oncohematology and immunology assessments
Apps and channels of Cytognos
its YouTube channel Cytognos has 989 subscribers and 30 videos.
Videos from Cytognos
The most watched videos on Cytognos's YouTube channel, Cytognos (989 subscribers). Click a video to play it here.
More on Cytognos.
Investors in Cytognos
Cytognos has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include BD and Vitro Master Diagnóstica.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
BD is recognized for providing innovative medical technology solutions. | 1897 | bd.com | Franklin Lakes, United States | |
Reagents for immunohistochemistry, molecular diagnostics, and instruments are developed. | 2014 | vitro.bio | Seville, Spain |
Investor details for Cytognos
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cytognos
2 people are tracked at Cytognos (2 in leadership).
| Name | Role | Group |
|---|---|---|
Fernando Lara | CEO | Leadership |
Santiago Sanchez Ferrer | WW Sales And Marketing Director | Leadership |
Complete people profiles for Cytognos
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cytognos
3 dated milestones of Cytognos across 26 years, from founding to its latest funding, stage changes and deals.
- Founded Cytognos is founded.
- Exit Acquired by Vitro.
- Exit Acquired by Becton Dickinson.
Web traffic of Cytognos
The website of Cytognos (cytognos.com) receives about 1.3K visits a month.
- Monthly visits1.3K
▼ 71.1% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cytognos
Complete news archive for Cytognos
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cytognos
Cytognos was founded in 1996.
Cytognos is headquartered in Santa Marta De Tormes, Spain. It is registered at Santa Marta De Tormes, Castilla Y Leon, Spain.
Development of reagents, software, and solutions for flow cytometry is conducted by Cytognos, which was founded in 1996. Compatibility with most existing flow cytometers is offered by the Infinicyt software, through which multidimensional analysis of antibody panels is enabled. The EuroFlow range of reagents and consumables is directed toward oncology applications, including multiple myeloma, acute lymphoblastic leukemia, B-cell non-Hodgkins lymphoma, and bladder cancer.
Cytognos offers Infinicyt Software, Antibodies, and Next Generation Flow.
Cytognos has 2 investors. Key investors include BD, and Vitro Master Diagnóstica.
Cytognos operates through Cytognos, S.L..
Yes. Cytognos was acquired by Becton Dickinson in February 2022.